Author

K.B. Priya

OpenAlex ID: A5121027452

27eP Real-world efficacy and safety of trastuzumab emtansine (T-DM1 Biosimilar, Ujvira) in early and metastatic HER2-positive breast cancer: A multicentre pooled retrospective analysis from India

2026 · S.S. Panda, A. Mahajan, et al. · ESMO Open

127P Study of the profile of HER2-positive metastatic breast cancer patients receiving T-DM1 biosimilar, in a real-world setting

2025 · A. Mahajan, S.S. Panda, et al. · Annals of Oncology

Works count: 2

Citation count:

H-index:

I10-index: